U.S. jury upheld validity of two patents for Amgen Inc’s cholesterol-lowering drug Repatha® (evolocumab)

US healthcare giant Amgen has successfully defended two of its patents related to cholesterol-lowering drug Repatha® (evolocumab). Amgen...